An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
CNS Neuroscience & Therapeutics · 2023
DOI: 10.1111/cns.14141 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Ye Hua und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Wuxi, China. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroblastoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear.
Methods
To access the alterations of NTN‐1 and DCC during the onset and progression of PD, we first established two subacute and one chronic PD model. Then, we investigated the relationship between the NTN‐1/DCC pathway and cell death in SH‐SY5Y cells. Finally, we conducted correlation studies between plasma NTN‐1 and parkinsonian symptoms in patients to understand how this pathway contributes to PD.
Results
We found that the imbalance of NTN‐1 and DCC was a common feature of nigral DA neuron injury in PD mouse models. We investigated that MPP+ inhibited NTN‐1 expression and increased DCC expression in a concentration‐ and time‐dependent manner. We further discovered a significant decrease in plasma NTN‐1 levels and a positive correlation with UPDRS scores in PD patients.
Conclusion
Our findings confirmed the imbalance of NTN‐1/DCC signaling during nigral degeneration in experimental PD models and found for the first time a correlation of plasma NTN‐1 with PD symptoms in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Wuxi, China.
- Neuroprotective Drug Discovery Center of Nanjing Medical University, Department of Pharmacology, Nanjing Medical University, Nanjing, China.
- Department of Clinical Laboratory, Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Wuxi, China.
- Department of Neurology, Xishan People's Hospital of Wuxi City, Wuxi, China.
ORCID-Profile: Yi Fan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hua, Y., Han, W., Zhou, L., Gao, J., Zhao, J., Song, N., Hu, B., Yao, Q., Liu, Y., Xu, D., Lu, Y., & Fan, Y. (2023). An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14141
Vancouver
Hua Y, Han W, Zhou L, Gao J, Zhao J, Song N, et al. An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14141
BibTeX
@article{Hua2023,
author = {Hua, Ye and Han, Wenjing and Zhou, Linfeng and Gao, Jing and Zhao, Jifeng and Song, Nanshan and Hu, Bin and Yao, Qingyu and Liu, Yumin and Xu, Deen and Lu, Yunnan and Fan, Yi},
title = {An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
doi = {10.1111/cns.14141}
}
EUVIMED